GeneDx Corp. (WGS)
NASDAQ: WGS
· Real-Time Price · USD
71.56
4.23 (6.28%)
At close: May 23, 2025, 3:59 PM
72.00
0.61%
After-hours: May 23, 2025, 05:38 PM EDT
6.28% (1D)
| Bid | 70.01 |
| Market Cap | 2.04B |
| Revenue (ttm) | 330.14M |
| Net Income (ttm) | -38.58M |
| EPS (ttm) | -1.39 |
| PE Ratio (ttm) | -51.48 |
| Forward PE | 33 |
| Analyst | Strong Buy |
| Ask | 72.58 |
| Volume | 566,899 |
| Avg. Volume (20D) | 1,142,949 |
| Open | 66.26 |
| Previous Close | 67.33 |
| Day's Range | 65.00 - 71.62 |
| 52-Week Range | 19.49 - 117.75 |
| Beta | 2.04 |
Analyst Forecast
According to 0 analyst ratings, the average rating for WGS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-42.85%
GeneDx Holdings shares are trading lower. The comp...
Unlock content with
Pro Subscription
2 months ago
+4.93%
GeneDx Holdings shares are trading higher after the company announced an indication expansion for its industry leading genetic testing to now include cerebral palsy.
